Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $8.7 million.

  • InfuSystem Holdings' Other Accumulated Expenses rose 829.6% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 829.6%. This contributed to the annual value of $7.8 million for FY2024, which is 141.48% up from last year.
  • According to the latest figures from Q3 2025, InfuSystem Holdings' Other Accumulated Expenses is $8.7 million, which was up 829.6% from $6.5 million recorded in Q2 2025.
  • InfuSystem Holdings' Other Accumulated Expenses' 5-year high stood at $8.7 million during Q3 2025, with a 5-year trough of $4.7 million in Q4 2021.
  • Its 5-year average for Other Accumulated Expenses is $6.7 million, with a median of $6.6 million in 2023.
  • As far as peak fluctuations go, InfuSystem Holdings' Other Accumulated Expenses surged by 5842.11% in 2021, and later tumbled by 3367.44% in 2022.
  • Over the past 5 years, InfuSystem Holdings' Other Accumulated Expenses (Quarter) stood at $4.7 million in 2021, then skyrocketed by 30.76% to $6.1 million in 2022, then grew by 25.76% to $7.7 million in 2023, then grew by 1.41% to $7.8 million in 2024, then increased by 11.28% to $8.7 million in 2025.
  • Its Other Accumulated Expenses was $8.7 million in Q3 2025, compared to $6.5 million in Q2 2025 and $7.6 million in Q1 2025.